The development of pharmaceutical products from laboratory scale to large-scale industrial production involves countless complex planning steps. Practice shows that planning error risks are very high, and every error means major additional cost later in the project. Having profound process knowledge and experience at your side will guide you safely around expensive pitfalls.

From lab to industry

The earliest point in time where ZETA can dock onto the production process of a biopharmaceutical agent is when the customer has mastered its production process at lab scale. From this early phase on, it is possible to analyze the process with a view to industrial-scale production and develop a concept for a pilot plant. This is where ZETA comes in and accompanies the customers through the entire process of clinical studies, supports the parallel scale-up to industrial scale and takes the appropriate plant engineering measures to assist a professional product launch.

Identify risks – minimize costs

We know from experience that the early involvement of process engineers in the concept design represents a real added value for any project. The early identification of potential risks minimizes unnecessary costs in the production phase later.